Guardant Health (GH) Misses Q4 EPS by 37c

Guardant Health (NASDAQ: GH) reported Q4 EPS of ($0.94), $0.37 worse than the analyst estimate of ($0.57). Revenue for the quarter came in at $78.3 million versus the consensus estimate of $76.73 million.

GUIDANCE:

Guardant Health sees FY2021 revenue of $360-370 million, versus the consensus of $377.07 million.

For earnings history and earnings-related data on Guardant Health (GH) click here.

You May Also Be Interested In

• Concentrix Corporation (CNXC) Misses Q2 EPS by 1c; Guides lower than expectations
• Guardant Health (GH) PT Raised to $160 at Guggenheim
• Freedom Broker Starts American States Water (AWR) at Hold